Project Grant R21NS147184
Award Date 9/1/26
Completion Date 8/31/28
Dollars Obligated $463K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New Haven, CT 06510, USA
Similar Awards
- The National Institute of Neurological Disorders and Stroke awarded the University of California, San Diego $129,186 on July 15, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate metabolic plasticity and neuronal resilience in response to chronic mitochondrial DNA damage. The research will characterize mitochondrial DNA distribution and motility in healthy versus mitochondrial DNA-compromised neurons using two...
- The National Institute of Neurological Disorders and Stroke awarded President and Fellows of Harvard College $595,961 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate mitochondrial DNA mutations and gene editing approaches in neural dysfunction. The research addresses mechanisms of central nervous system dysfunction triggered by mitochondrial DNA (mtDNA) mutations, particularly mutations in...
- The National Institute of Neurological Disorders and Stroke awarded Brandeis University $436,864 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate the molecular mechanisms by which hypoxia and genetic suppressors rescue mitochondrial Complex I function. The research combines C. elegans genetics, mitochondrial biochemistry, and cryogenic electron microscopy to define the structural basis of hypoxia...
- The National Institute of Neurological Disorders and Stroke awarded Yale University $462,052 under Project Grant R21NS150995 on August 21, 2026, to develop an automated, scalable framework for linking neuronal activity with genetic identity across the peripheral and central nervous systems. The project addresses a gap in current neuroscience methodology by integrating in vivo imaging of neuronal dynamics with spatial transcriptomics to map gene expression patterns directly to neural activity...
- The National Institute of Neurological Disorders and Stroke awarded $402,347 to the University of Georgia Research Foundation, Inc. on September 2, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853, Assistance Listing 93.853) to develop an extracellular vesicle-based platform for delivering healthy mitochondria to nerve cells affected by neurodegenerative diseases including amyotrophic lateral sclerosis, Alzheimer's disease, and...
- The National Institute of Neurological Disorders and Stroke awarded Northwestern University $214,329 on May 6, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate infection-driven inflammation as a driver of neurodegeneration in primary mitochondrial diseases. The research characterizes immune dysfunction across genetic forms of human primary mitochondrial disease through immunophenotyping and functional assessment,...
- The National Institute of Neurological Disorders and Stroke, part of the Department of Health and Human Services National Institutes of Health, awarded The Research Foundation for the State University of New York $645,070 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds research investigating mitochondrial gene regulation in central nervous system development, with focus on how the transcription...
- The National Institute of Neurological Disorders and Stroke awarded $132,133 to The Trustees of The University of Pennsylvania on December 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to define the degradative and inflammatory responses to mitochondrial damage in astrocytes. The research addresses how astrocytes, the most abundant cell type in the brain, respond to mitochondrial dysfunction associated with Parkinson's...
- The National Institute of Neurological Disorders and Stroke awarded The Trustees of Columbia University in the City of New York $126,900 on March 7, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds research to exploit RNA biogenesis, specifically alternative splicing programs, to accelerate maturation of human neurons in vitro and to develop models of age-related tauopathies. The research addresses a fundamental...
- The National Institute of Neurological Disorders and Stroke awarded Icahn School of Medicine at Mount Sinai $670,266 on January 20, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to map the epigenomic and spatial transcriptomic landscape in Parkinson's disease and Alzheimer's disease. The project characterizes shared and distinct transcriptional changes between Parkinson's disease, Alzheimer's disease, and Alzheimer's...